Jynneos was the first smallpox vaccine developed under Project BioShield, a program created by Congress in 2004 to accelerate ...

Yesterday the US Food and Drug Administration (FDA) approved a freeze-dried formulation of Bavarian Nordic's mpox vaccine, ...

Healthcare personnel (HCP) in Greece who were ill with COVID-19 and had at least one underlying medical condition missed more ...

A Washington Post report on March 28 that the US Department of Health and Human Services (HHS) forced the Food and Drug ...

The New York State Department of Agriculture and Markets on March 28 warned consumers about the risk of H5N1 avian flu from ...

Contracting a non-COVID lower respiratory tract infection raises the risk of death 2 to 7 times over the next month to a year ...

A preprint study posted late last week on the server medRxiv reveals that the current Moderna COVID-19 vaccine is 53% effective against COVID-19–related hospitalization and 39% protective against ...

Even better, they discovered that lariocidin—named for its knotted, lasso-like chemical structure—has a unique mechanism of ...

A cholera outbreak in Angola has spread to 16 of the country's 21 provinces since the first of the year, the World Health ...

One dose of the Jynneos vaccine was 58% effective against mpox infection overall and 84% in people without HIV, but only 35% ...

Notably, the authors found that people who later had persistent COVID-19 symptoms following acute infections—or long ...

When it comes to antibiotic stewardship and clinical care, Brad Spellberg, MD, just wants to see the data.